Molekule

Dr. Daniel Pascheles Rejoins Molekule Consulting as Strategic Advisor

Retrieved on: 
Monday, October 30, 2023

MIAMI, FL, Oct 31, 2023 - (ACN Newswire) - In a significant development that promises to shape the future of Molekule Consulting, we are thrilled to announce the return of Dr. Daniel Pascheles as a Strategic Advisor.

Key Points: 
  • MIAMI, FL, Oct 31, 2023 - (ACN Newswire) - In a significant development that promises to shape the future of Molekule Consulting, we are thrilled to announce the return of Dr. Daniel Pascheles as a Strategic Advisor.
  • Dr. Pascheles, with an illustrious career spanning over 30 years in the biopharmaceutical competitive and strategic intelligence sector, is poised to bring a wealth of knowledge and expertise to Molekule.
  • Pascheles!"
  • In his pivotal role as Strategic Advisor, Dr. Pascheles will employ his vast industry expertise and strategic prowess to shape and foster Molekule's trajectory of growth and value journey into the future.

Molekule's PECO technology demonstrates power of pollutant destruction in air purification

Retrieved on: 
Thursday, August 24, 2023

PALM BEACH GARDENS, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), a leading air purification technology company, today announced new laboratory results that highlight the power of the Company’s proprietary photoelectrochemical oxidation (“PECO”) technology and its ability to destroy what conventional filters leave behind.

Key Points: 
  • Three new studies were completed, including one from Florida International University, that demonstrate that Molekule’s PECO technology can safely destroy a vast range of indoor air pollutants.
  • PECO technology for air purification reacts with ultraviolet light to oxidize pollutants, including viruses, bacteria, mold, ozone, allergens, volatile organic compounds, particles found in smoke and chemicals, and break them down into harmless molecules.
  • PECO technology not only captures but destroys pollutants at a microscopic scale, ultimately helping people who suffer from specific pollutant triggers breathe better air,” said Jaspreet Dhau, Molekule’s vice president and head of research and development.
  • For more information about how Molekule’s patented PECO technology detects and destroys organic pollutants, please visit molekule.com.

Molekule Reports Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 16, 2023

PALM BEACH GARDENS, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), a leading air purification technology company, today reported financial results for the three months (“Q2 2023”) ended June 30, 2023.

Key Points: 
  • PALM BEACH GARDENS, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), a leading air purification technology company, today reported financial results for the three months (“Q2 2023”) ended June 30, 2023.
  • Revenues were $13.2 million, an increase of 58% as compared to the first quarter of 2023.
  • Filter sales of $9.5 million increased approximately 63% as compared to the first quarter of 2023 reflecting a strong and increasing base of recurring revenues.
  • Financial results and analyses are available on the Company’s investor relations website: https://investors.molekule.com .

Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors

Retrieved on: 
Thursday, August 10, 2023

TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.

Key Points: 
  • TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023.
  • Mr. Scannell joined Synaptive Medical's Board of Directors in August 2022, bringing a wealth of experience and expertise in the medical device industry.
  • In addition to his service on the Synaptive board, Mr. Scannell currently serves as a director on the boards of publicly held Insulet, Novocure, Renalytix and MoleKule.
  • "We are thrilled to welcome Tim Scannell as the Chair of our Board of Directors.

Europe Air Purifiers Market Report 2023: New Air Purifier Launches Take the European Market by Storm - Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 4, 2023

In the industrial setting, air purifiers can be utilized to clean the air before processing.

Key Points: 
  • In the industrial setting, air purifiers can be utilized to clean the air before processing.
  • Technology-based air purifiers are further influencing the growth of the air purifiers market in Europe.
  • Therefore, rising air pollution drives the market for air purifiers in Europe.
  • Company Profiles: Detailed analysis of the major companies present in Europe air purifiers market.

Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer

Retrieved on: 
Wednesday, July 26, 2023

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer.

Key Points: 
  • Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today announces the appointment of executive Jonathan Harris as its new President and Chief Revenue Officer.
  • With a proven track record in leading go-to-market strategies for some of the world’s top brands including Microsoft, Roku, GoPro, and Jawbone, Harris brings more than 30 years of experience to Owlet.
  • Harris scaled GoPro from $19 Million to more than $1.5 Billion in revenue globally and helped lead the company through its initial public offering (IPO).
  • "We're thrilled to welcome Jonathan to the Owlet team.

Molekule launches ‘Molekule 360,’ first-of-its-kind indoor air quality management solution

Retrieved on: 
Tuesday, July 18, 2023

PALM BEACH GARDENS, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), a leading air purification technology company, today announced the launch of Molekule 360, a first-of-its-kind indoor air quality (“IAQ”) management solution.

Key Points: 
  • Salesforce and one of the largest U.S. banks are participating in the initial deployment of Molekule’s newly developed, Molekule 360, Indoor Air Quality (“IAQ”) management system
    Powered by the Molekule 360 Hub and artificial intelligence (“AI”) insights, the turnkey solution enables proactive control of air quality in public and commercial indoor spaces
    PALM BEACH GARDENS, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), a leading air purification technology company, today announced the launch of Molekule 360 , a first-of-its-kind indoor air quality (“IAQ”) management solution.
  • The comprehensive indoor air quality management solution is an intuitive, easy-to-use platform that provides real-time, AI-enabled IAQ insights across an organization’s building portfolio.
  • Native enterprise control: Molekule 360 features built-in support for thousands of Molekule purifiers enabling monitoring and automatic air quality management right out of the box and from a single location.
  • “Implementing Molekule 360 has revolutionized our approach to indoor air quality management,” said Ilan Zachar, chief technology officer at Carr Properties.

Test Results Indicate that Molekule’s Air Pro Purifier Reduces Hospital Length of Stay by Approximately Two Days in COVID-19 Patients

Retrieved on: 
Tuesday, June 27, 2023

PALM BEACH GARDENS, Fla., June 27, 2023 (GLOBE NEWSWIRE) --  Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL) today announced the results of a research study evaluating the effect of in-room air purification on the clinical recovery in mild and moderate COVID-19 patients. The study, conducted at two Mercyhealth hospitals, indicates a statistically significant outcome, with length of stay reduced by approximately two (2) days when Molekule’s Air Pro purifier with its patented PECO filter is running in the patient room.

Key Points: 
  • The study, conducted at two Mercyhealth hospitals, indicates a statistically significant outcome, with length of stay reduced by approximately two (2) days when Molekule’s Air Pro purifier with its patented PECO filter is running in the patient room.
  • “We know our devices are proven to effectively destroy many dangerous pathogens from the air.
  • “The results from the adequately powered blinded randomized controlled trial comparing Molekule’s Air Pro purifier versus placebo shows that, on average, use of Molekule’s Air Pro purifier was associated with a two day shorter stay in the hospital for COVID-19 patients - the primary outcome of the trial.
  • On average, patients with Air Pro devices with filter use stayed two days less in the hospital compared with placebo devices.

Molekule Reports First Quarter 2023 Financial Results

Retrieved on: 
Tuesday, May 16, 2023

PALM BEACH GARDENS, Fla., May 16, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), an emerging leader in air purification technology solutions, systems for healthcare and commercial smart building applications, and individual consumer protection, today reported financial results for the three months ended March 31, 2023 (“Q1 2023”).

Key Points: 
  • Changed the Company name to Molekule Group, Inc. and began trading under a new ticker symbol (NASDAQ: MKUL), upon completion of the merger with Molekule, Inc. (“Molekule Merger”) on January 12, 2023.
  • “I am very proud of the results we achieved during our first quarter as a combined company,” said Jason DiBona, Chief Executive Officer of Molekule.
  • We believe our integration is proceeding exceptionally well with Q1 2023 revenue of $8.3 million exceeding our guidance for the quarter.
  • Financial results and analyses are available on the Company’s investor relations website: https://investors.molekule.com/ .

Molekule Group, Inc. Announces Closing of $10.0 Million Private Placement and Deferral of $6.0 million Principal Amortization Through 2025

Retrieved on: 
Tuesday, May 9, 2023

PALM BEACH GARDENS, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), reported today the closing of its previously-announced approximately $10 million private placement with a single institutional investor.

Key Points: 
  • PALM BEACH GARDENS, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), reported today the closing of its previously-announced approximately $10 million private placement with a single institutional investor.
  • The Series B Warrants and the Pre-Funded Warrant terminate five years after they become exercisable.
  • The Company also agreed to reduce the exercise price of 1,500,000 outstanding warrants owned by the institutional investor to $2.00.
  • The Benchmark Company and Roth Capital Partners acted as the exclusive placement agents for the private placement.